Apple has filed a new inter partes review, IPR2026-00340, at the Patent Trial and Appeal Board on April 24, 2026, opening another closely watched front in the company’s patent dispute strategy. The proceeding is captioned Apple Inc., and, as with many newly filed PTAB matters, practitioners will be watching the petition and any forthcoming preliminary response to see how the issues are framed before the Board decides whether to institute review.

At this early stage, the public docket identifies Apple as the petitioner but may not yet provide the full set of details practitioners typically want immediately, including the patent owner’s identity, the patent number being challenged, and the precise prior-art grounds asserted. Those core details generally emerge from the petition, mandatory notices, and later-filed papers. Even so, the filing itself is significant: when a major technology company initiates an IPR, it often signals parallel district court litigation, licensing pressure, or a broader portfolio-level invalidity campaign.

Once the petition is fully available, the key issues for patent counsel will be familiar but consequential. First, what patent claims are under attack, and how central are they to any ongoing infringement case? Second, what statutory grounds has Apple raised—most commonly anticipation under 35 U.S.C. § 102 or obviousness under § 103 based on patents and printed publications? Third, how does the petition address PTAB hot-button issues such as claim construction, motivation to combine, reasonable expectation of success, and any objective indicia that may be raised in response?

This proceeding is worth following not only because of the petitioner, but because PTAB filings involving sophisticated repeat players often provide a useful look at current petition-drafting tactics. Apple’s IPRs frequently showcase detailed prior-art mapping, strategic use of expert declarations, and careful positioning on discretionary-denial issues. Patent owners and challengers alike can draw practical lessons from how the parties handle institution-stage briefing, estoppel considerations, and any overlap with parallel proceedings.

For in-house IP counsel, the case may also offer insight into how large operating companies continue to use the PTAB as part of a broader risk-management toolkit. For patent prosecutors and litigators, it is another reminder that claim scope, specification support, and prosecution history can all become critical in post-grant review.

View full case on Docket Alarm